v3.26.3
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Series A Non-Voting Convertible
Preferred Stock
Series A Convertible
Preferred Stock
Series B Convertible
Preferred Stock
Series C/C-1 Convertible
Preferred Stock
Common stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024   $ 5,231 $ 13,701 $ 46,217 $ 5,753 $ (124,958) $ (119,205)
Balance (in Shares) at Dec. 31, 2024   4,350,314 5,293,175 8,220,445 258      
Stock-based compensation expense   5 5
Net loss   (2,716) (2,716)
Balance at Mar. 31, 2025   $ 5,231 $ 13,701 $ 46,217 5,758 (127,674) (121,916)
Balance (in Shares) at Mar. 31, 2025   4,350,314 5,293,175 8,220,445 258      
Balance at Dec. 31, 2024   $ 5,231 $ 13,701 $ 46,217 5,753 (124,958) (119,205)
Balance (in Shares) at Dec. 31, 2024   4,350,314 5,293,175 8,220,445 258      
Net loss               (31,154)
Balance at Sep. 30, 2025   122,201 (156,112) (33,911)
Balance (in Shares) at Sep. 30, 2025   5,560      
Balance at Dec. 31, 2024   $ 5,231 $ 13,701 $ 46,217 5,753 (124,958) (119,205)
Balance (in Shares) at Dec. 31, 2024   4,350,314 5,293,175 8,220,445 258      
Balance at Dec. 31, 2025       134,123 (160,781) (26,658)
Balance (in Shares) at Dec. 31, 2025       12,320      
Balance at Mar. 31, 2025   $ 5,231 $ 13,701 $ 46,217 5,758 (127,674) (121,916)
Balance (in Shares) at Mar. 31, 2025   4,350,314 5,293,175 8,220,445 258      
Stock-based compensation expense   82 82
Net loss   (2,348) (2,348)
Balance at Jun. 30, 2025   $ 5,231 $ 13,701 $ 46,217 5,840 (130,022) (124,182)
Balance (in Shares) at Jun. 30, 2025   4,350,314 5,293,175 8,220,445 258      
Issuance of shares in connection with exercise of ELOC   3,537 3,537
Issuance of shares in connection with exercise of ELOC (in shares)         1,076      
Issuance of shares in connection with the conversion of the PIPE note  
Issuance of shares in connection with the conversion of the PIPE note (in Shares)         120      
Issuance of warrants in connection with PIPE notes   982 982
Conversion of preferred stock into common stock   $ (5,231) $ (13,701) $ (46,217) 65,149 65,149
Conversion of preferred stock into common stock (In Shares)   (4,350,314) (5,293,175) (8,220,445) 823      
Common stock issued to employees   428 428
Common stock issued to employees (In Shares)         63      
Conversion of Debt to Common Shares in Connection with the Merger   46,891 46,891
Conversion of Debt to Common Shares in Connection with the Merger (In Shares)         1,970      
Issuance of common stock to Northview stockholders as a result of the merger   (8,399) (8,399)
Issuance of common stock to Northview stockholders as a result of the merger (in shares)         864      
Issuance of induced common shares to related party in connection with the merger   7,254 7,254
Issuance of induced common shares to related party in connection with the merger (in shares)         386      
Issuance of warrants to financial advisor in connection with the merger   330 330
Stock-based compensation expense   189 189
Net loss   (26,090) (26,090)
Balance at Sep. 30, 2025   122,201 (156,112) (33,911)
Balance (in Shares) at Sep. 30, 2025   5,560      
Balance at Dec. 31, 2025       134,123 (160,781) (26,658)
Balance (in Shares) at Dec. 31, 2025       12,320      
Issuance of shares in connection with exercise of ELOC       469 469
Issuance of shares in connection with exercise of ELOC (in shares)         3,214      
Issuance of shares in connection with the conversion of the PIPE note       1,260 1,260
Issuance of shares in connection with the conversion of the PIPE note (in Shares)         8,266      
Stock-based compensation expense       187 187
Net loss       (3,456) (3,456)
Balance at Mar. 31, 2026       136,039 (164,237) (28,198)
Balance (in Shares) at Mar. 31, 2026       23,800      
Balance at Dec. 31, 2025       134,123 (160,781) (26,658)
Balance (in Shares) at Dec. 31, 2025       12,320      
Net loss               (17,161)
Balance at Sep. 30, 2026       185,737 (177,942) 7,795
Balance (in Shares) at Sep. 30, 2026 58,832.859       2,516,564      
Balance at Mar. 31, 2026       136,039 (164,237) (28,198)
Balance (in Shares) at Mar. 31, 2026       23,800      
Issuance of shares in connection with exercise of ELOC       2,471 2,471
Issuance of shares in connection with exercise of ELOC (in shares)         89,806      
Issuance of shares in connection with the conversion of the PIPE note       3,460 3,460
Issuance of shares in connection with the conversion of the PIPE note (in Shares)         18,702      
Issuance of warrants in connection with PIPE notes       1,798 1,798
Reversal of excise tax payable attributable to redemption of common stock       1,909 1,909
Stock-based compensation expense       188 188
Net loss       (8,755) (8,755)
Balance at Jun. 30, 2026       145,865 (172,992) (27,127)
Balance (in Shares) at Jun. 30, 2026       132,308      
Issuance of Series A Non-Voting Convertible Preferred Stock for Settlement of Liabilities       3,051 3,051
Issuance of Series A Non-Voting Convertible Preferred Stock for Settlement of Liabilities (In Shares) 5,929.293              
Issuance of Series A non-voting convertible preferred stock and common stock in connection with G3 Call Option issuance       28,327 28,327
Issuance of Series A non-voting convertible preferred stock and common stock in connection with G3 Call Option issuance (In Shares) 52,903.566       50,280      
Issuance of shares in connection with the conversion of the related party convertible promissory note       1,166 1,166
Issuance of shares in connection with the conversion of the related party convertible promissory note (In Shares)         301,991      
Issuance of Shares in Connection with the Conversion of the Pipe Note       7,203 7,203
Issuance of Shares in Connection with the Conversion of the Pipe Note (In Shares)         2,032,092      
Cancellation of Fractional Shares in Connection with August Reverse Stock Split       (1) (1)
Cancellation of Fractional Shares in Connection with August Reverse Stock Split (In Shares)         (107)      
Stock-based compensation expense       126 126
Net loss       (4,950) (4,950)
Balance at Sep. 30, 2026       $ 185,737 $ (177,942) $ 7,795
Balance (in Shares) at Sep. 30, 2026 58,832.859       2,516,564